Logo-bi
Review

1. Nanomaterials as Non-viral siRNA Delivery Agents for Cancer Therapy
Sanjay Singh*
Bioimpacts. 2013;3(2): 53-65. doi: 10.5681/bi.2013.007
PMCID: PMC3713871     PMID: 23878788     Scopus ID: 84881502609    
Article
PDF
XML
Cited By:
38
7
0
Review

2. Targeting tumor microenvironment: crossing tumor interstitial fluid by multifunctional nanomedicines
Yadollah Omidi ORCID, Jaleh Barar* ORCID
Bioimpacts. 2014;4(2): 55-67. doi: 10.5681/bi.2014.021
PMCID: PMC4097973     PMID: 25035848     Scopus ID: 84905435584    
Article
PDF
XML
Cited By:
117
40
0
Review

3. Impacts of quantum dots in molecular detection and bioimaging of cancer
Omid Mashinchian, Mohammad Johari-Ahar, Behnaz Ghaemi, Mohammad Rashidi, Jaleh Barar* ORCID, Yadollah Omidi* ORCID
Bioimpacts. 2014;4(3): 149-166. doi: 10.15171/bi.2014.008
PMCID: PMC4204040     PMID: 25337468     Scopus ID: 84908221773    
Article
PDF
XML
Cited By:
83
27
77
Editorial

4. Bioimpacts of nanoparticle size: why it matters?
Jaleh Barar* ORCID
Bioimpacts. 2015;5(3): 113-115. doi: 10.15171/bi.2015.23
PMCID: PMC4597157     PMID: 26457247     Scopus ID: 84944413654    
Article
PDF
XML
Cited By:
8
8
16
Editorial

5. CNT Nanobombs for Specific Eradication of Cancer Cells: A New Concept in Cancer Theranostics
Yadollah Omidi* ORCID
Bioimpacts. 2011;1(4): 199-201. doi: 10.5681/bi.2011.028
PMCID: PMC3648969     PMID: 23678428     Scopus ID: 84876726247    
Article
PDF
XML
Cited By:
13
6
0
Editorial

6. Smart Multifunctional Theranostics: Simultaneous Diagnosis and Therapy of Cancer
Yadollah Omidi* ORCID
Bioimpacts. 2011;1(3): 145-147. doi: 10.5681/bi.2011.019
PMCID: PMC3648960     PMID: 23678419     Scopus ID: 84865491877    
Article
PDF
XML
Cited By:
54
19
0
Review

7. Impacts of Blood-Brain Barrier in Drug Delivery and Targeting of Brain Tumors
Yadollah Omidi* ORCID, Jaleh Barar ORCID
Bioimpacts. 2012;2(1): 5-22. doi: 10.5681/bi.2012.002
PMCID: PMC3648919     PMID: 23678437     Scopus ID: 84876731279    
Article
PDF
XML
Cited By:
58
19
0
Review

8. Stimuli-responsive chitosan-based nanocarriers for cancer therapy
Marziyeh Fathi, Parham Sahandi Zangabad, Sima Majidi, Jaleh Barar, Hamid Erfan-Niya, Yadollah Omidi* ORCID
Bioimpacts. 2017;7(4): 269-277. doi: 10.15171/bi.2017.32
PMCID: PMC5801539     PMID: 29435435     Scopus ID: 85041008382    
Article
PDF
Full Text
XML
Cited By:
59
11
52
Review

9. Combating atherosclerosis with targeted nanomedicines: recent advances and future prospective
Ailar Nakhlband, Morteza Eskandani, Yadollah Omidi ORCID, Nazli Saeedi, Samad Ghafari, Jaleh Barar* ORCID, Alireza Garjani*
Bioimpacts. 2018;8(1): 59-75. doi: 10.15171/bi.2018.08
PMCID: PMC5915710     PMID: 29713603     Scopus ID: 85044298919    
Article
PDF
Full Text
XML
Cited By:
50
11
45
Editorial

10. Recent advances in targeted therapy of colorectal cancer: impacts of monoclonal antibodies nanoconjugates
Mostafa Akbarzadeh Khiavi ORCID, Azam Safary ORCID, Mohammad Hossein Somi* ORCID
Bioimpacts. 2019;9(3): 123-127. doi: 10.15171/bi.2019.16
PMCID: PMC6726747     PMID: 31508327     Scopus ID: 85071152476    
Article
PDF
Full Text
XML
Cited By:
20
9
19
Colorectal cancer (CRC) as a malignancy shows high mortality rate worldwide because of metastasis and drug resistance. Targeted multimodal nanosystems (NSs) can be developed and used against CRC with much better clinical outcomes.

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate: 24% 
Publication fee: Free of charge